RNA Therapeutics - Research and Clinical Advancements

Rundong Feng,Suryaji Patil,Xin Zhao,Zhiping Miao,Airong Qian
DOI: https://doi.org/10.3389/fmolb.2021.710738
IF: 6.113
2021-09-22
Frontiers in Molecular Biosciences
Abstract:RNA therapeutics involve the use of coding RNA such as mRNA as well as non-coding RNAs such as small interfering RNAs (siRNA), antisense oligonucleotides (ASO) to target mRNA, aptamers, ribozymes, and clustered regularly interspaced short palindromic repeats-CRISPR-associated (CRISPR/Cas) endonuclease to target proteins and DNA. Due to their diverse targeting ability and research in RNA modification and delivery systems, RNA-based formulations have emerged as suitable treatment options for many diseases. Therefore, in this article, we have summarized different RNA therapeutics, their targeting strategies, and clinical progress for various diseases as well as limitations; so that it might help researchers formulate new and advanced RNA therapeutics for various diseases. Additionally, U.S. Food and Drug Administration (USFDA)-approved RNA-based therapeutics have also been discussed.
biochemistry & molecular biology
What problem does this paper attempt to address?